• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Why agilon health (AGL) Stock Is Down Today

By: StockStory
August 20, 2025 at 12:45 PM EDT

AGL Cover Image

What Happened?

Shares of healthcare services company Agilon Health (NYSE: AGL) fell 4.4% in the afternoon session after the company was downgraded by analysts at Bernstein from “Outperform” to “Market Perform”. The firm also slashed its price target on the stock by 65% to $1.40 from $4.00. Analyst Lance Wilkes cited “worse-than-expected margin pressures” following a disappointing quarter where the company's medical margin was a negative $53 million. This was primarily driven by lower-than-expected risk adjustment revenue for 2024 and 2025. Bernstein expressed concerns about agilon's reduced capital, which increases its cost of capital, and noted cash flow uncertainty after the company withdrew its fiscal year 2025 guidance.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy agilon health? Access our full analysis report here, it’s free.

What Is The Market Telling Us

agilon health’s shares are extremely volatile and have had 80 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 2 days ago when the stock gained 8.1% on the news that the stock extended its positive momentum as it bounced back from a significant dip. The rally follows a difficult period for the company, which saw its stock plunge over 50% after the CEO stepped down and full-year 2025 financial guidance was withdrawn on August 4. The move appears to have a technical component, as the stock gained for four consecutive days after.

agilon health is down 36.7% since the beginning of the year, and at $1.22 per share, it is trading 78.6% below its 52-week high of $5.68 from April 2025. Investors who bought $1,000 worth of agilon health’s shares at the IPO in April 2021 would now be looking at an investment worth $39.19.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.

More News

View More
Microsoft 365 Premium Marks the Next Phase of AI Monetization
October 12, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers MSFT
Could Target’s Week of Discounts Come Full Circle for Investors?
October 12, 2025
Via MarketBeat
Topics Economy
Tickers AAPL GE TGT WMT
3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
October 12, 2025
Via MarketBeat
Tickers SFM
Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
October 11, 2025
Via MarketBeat
Tickers BSET ETD HVT
AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon
October 11, 2025
Via MarketBeat
Tickers ASTS JOBY RGTI T VOD VZ
Recent Quotes
View More
Symbol Price Change (%)
GOOG  237.49
+0.00 (0.00%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap